EAS warmly congratulates Professor Wiegman on his outstanding contribution to paediatric lipidology, particularly his pioneering work in familial hypercholesterolaemia and lifelong cardiovascular prevention. Read more

Familial hypercholesterolaemia (FH) is a common genetic disorder characterized by lifelong elevated low-density lipoprotein cholesterol (LDL-C) concentrations, which increase the risk of premature…

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide, responsible for one in three deaths globally. Despite major advances in lipid testing, preventive…

This course aims to provide a solid understanding of lipoprotein(a) [Lp(a)], including its molecular structure and its role in the development of atherosclerosis. It covers…

In this episode of AtheroTalk, we are honored to host Prof. John J.P. Kastelein, one of the most influential figures in lipidology and cardiovascular prevention. With…

Basic Science Award:Imidazole propionate is a driver and therapeutic target in atherosclerosisAwardee: Annalaura Mastrangelo, Spanish National Center for Cardiovascular Research (CNIC), Madrid, SpainPublished in Nature…

Kokshetau city, march 6, 2026

Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: A meta-analysis The National Lipid Association (NLA) has published an…

Improving recognition, diagnosis, and management of rare dyslipidaemias Rare lipid disorders, such as homozygous familial hypercholesterolaemia (HoFH) and familial chylomicronaemia syndrome (FCS), are serious and…

Please log in to register for the General Assembly >

Acknowledgement EAS have independently organised all matters related to this activity. The Society gratefully acknowledges financial support from Raisio. Webinar #1 Diet for prevention and…

The ELC meeting offers a unique and intimate setting with around 110 participants, bringing together principal investigators, postdocs, and graduate students for high-level scientific exchange…

Organised by FH Europe | Endorsed by the European Atherosclerosis Society (EAS) This February, join a free, patient-focused webinar trilogy organised by FH Europe and…

Acknowledgement EAS have independently organised all matters related to this activity. The Society gratefully acknowledges financial support from Chiesi. Webinar #1 Homozygous Familial Hypercholesterolemia Management:…

Our guest, Prof. Göran K. Hansson, has spent a lifetime advancing cardiovascular science while helping steward one of the world’s most prestigious scientific institutions. His…

On the publication of the EU Cardiovascular Health Plan – the “Safe Hearts Plan” In line with the Safe Hearts Plan, and building on the…

We are delighted to announce that Professor Heribert Schunkert has been awarded the 2026 Anitschkow Prize for his pioneering work in the genetics of atherosclerosis…

The EACH Cardiovascular Health Summit 2025 gathers policymakers, researchers, patients, and health leaders in Brussels on 10–11 December to advance a shared vision for improved cardiovascular health…

In this AtheroTalk episode, Prof. Frederick Raal – a distinguished Professor at the University of the Witwatersrand and one of the world’s leading experts in…

The call for nominations for the EAS Young Investigator Awards will be open from December 1, 2025 to February 2, 2026, with results announced in…

Society: Young Investigator Awards for outstanding publications, call for nominations opens With these annual Young Investigator Awards for outstanding publications, EAS recognizes excellence that contributes…

In this episode of AtheroTalk, Prof. Ron Blankstein, a leading expert in cardiovascular imaging and prevention, discusses his professional journey, the power of coronary artery…

Hypertriglyceridemia and Atherosclerosis: Beyond LDL-C At the 2025 European Atherosclerosis Society (EAS) Congress in Glasgow, Professor Michael D. Shapiro, Fred M. Parrish Professor of Cardiology…

We are pleased to announce that the full recordings from the EAS Congress 2025 are now available on the EAS Academy platform. Participants can revisit…

In this episode of the AtheroTalk, we speak with Dr Rohan Khera from the Yale School of Medicine – a leading expert in big data…

Society: Announcing candidates for Election Committee 2026-2028 EAS members are invited to select the members of the Election Committee 2026-2028 by means of an online…

This episode explores the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias, highlighting key changes in cardiovascular risk assessment, LDL-C…

Acute Coronary Syndromes in the absence of standard modifiable risk factors (SMURFs): Is sex the missing link? by Prof. Gemma Figtree In this lecture, Prof.…

We sit down with Prof. Bart van de Sluis, Professor of Molecular Genetics and Translational Biology at the University of Groningen (UMCG). His research unravels…

The Lipid Clinic Network local webinars on the Focused Update are tailor-made sessions designed to support national dissemination of the new guidance, enable adaptation to…

This time, we interview Prof. Michael Shapiro, President of the American Association of Preventive Cardiology and Chair-Elect of the AHA Council on Lipidology, Lipoprotein, Metabolism…

Brussels, 29 September 2025 — The European Alliance for Cardiovascular Health (EACH) is bringing together World Heart Day (29 September) and World Stroke Day (29…

Join us for EAS FH Week 2025! Familial Hypercholesterolaemia (FH) remains underdiagnosed and undertreated — and demands urgent action. During FH Week 2025, EAS will…

Tune in to this special FH Awareness Week episode of our podcast featuring Prof. Steve Humphries. In this conversation, he shares valuable insights into familial…